IR-Med (IR-Med) ROCE % : -580.23% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is IR-Med ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IR-Med's annualized ROCE % for the quarter that ended in Dec. 2023 was -580.23%.

IR-Med ROCE % Historical Data

The historical data trend for IR-Med's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IR-Med ROCE % Chart

IR-Med Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

-47.42

-180.36

-182.55

-311.02

IR-Med Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial									-252.44	-238.40	-224.15	-296.01	-580.23

IR-Med ROCE % Calculation

IR-Med's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-4.911	/	( ( (3.294 - 0.662)	+	(0.999 - 0.473) )	/ 2 )
	=	-4.911	/	( (2.632	+	0.526)	/ 2 )
	=	-4.911	/	1.579
	=	-311.02 %

IR-Med's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-5.048	/	( ( (1.773 - 0.559)	+	(0.999 - 0.473) )	/ 2 )
	=	-5.048	/	( ( 1.214	+	0.526 )	/ 2 )
	=	-5.048	/	0.87
	=	-580.23 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

IR-Med (OTCPK:IRME) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IR-Med ROCE % Related Terms

Thank you for viewing the detailed overview of IR-Med's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

IR-Med (IR-Med) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IR-Med Inc (OTCPK:IRME) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400

Website

https://www.ir-medical.com

IR-Med Inc is a medical device company that specializes in infrared-based technologies. It develops medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies.